Tinavi Historical Income Statement

688277 Stock   10.66  0.08  0.74%   
Historical analysis of Tinavi Medical income statement accounts such as Interest Income of 2.1 M, Interest Expense of 6.7 M or Selling General Administrative of 105.6 M can show how well Tinavi Medical Technologies performed in making a profits. Evaluating Tinavi Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tinavi Medical's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Tinavi Medical Techn latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tinavi Medical Techn is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tinavi Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Tinavi Income Statement Analysis

Tinavi Medical Techn Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tinavi Medical shareholders. The income statement also shows Tinavi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Tinavi Medical Income Statement Chart

At present, Tinavi Medical's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 6.7 M, whereas Net Interest Income is projected to grow to (3.5 M).

Total Revenue

Total revenue comprises all receipts Tinavi Medical Techn generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tinavi Medical Techn. It is also known as Tinavi Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Tinavi Medical Techn income statement and represents the costs associated with goods and services Tinavi Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Tinavi Medical Techn financial statement analysis. It represents the amount of money remaining after all of Tinavi Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Tinavi Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tinavi Medical Techn current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tinavi Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Tinavi Medical's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 6.7 M, whereas Net Interest Income is projected to grow to (3.5 M).
 2021 2022 2023 2024 (projected)
Gross Profit106.1M102.6M149.4M126.3M
Total Revenue156.0M156.2M210.0M170.9M

Tinavi Medical income statement Correlations

-0.43-0.190.060.030.060.25-0.08-0.090.19-0.140.16-0.09-0.04-0.250.07-0.080.10.05
-0.430.02-0.51-0.36-0.28-0.910.660.630.42-0.460.48-0.54-0.49-0.50.560.620.650.42
-0.190.020.570.570.480.35-0.68-0.7-0.790.76-0.710.770.680.76-0.73-0.7-0.66-0.31
0.06-0.510.570.960.910.72-0.88-0.9-0.850.93-0.890.890.980.79-0.89-0.89-0.8-0.2
0.03-0.360.570.960.990.58-0.78-0.81-0.790.87-0.820.80.930.69-0.81-0.81-0.69-0.2
0.06-0.280.480.910.990.48-0.68-0.72-0.690.77-0.740.690.860.56-0.71-0.72-0.57-0.11
0.25-0.910.350.720.580.48-0.89-0.88-0.750.75-0.780.80.740.77-0.84-0.88-0.89-0.41
-0.080.66-0.68-0.88-0.78-0.68-0.890.990.95-0.940.95-0.93-0.92-0.890.981.00.970.31
-0.090.63-0.7-0.9-0.81-0.72-0.880.990.96-0.950.96-0.94-0.93-0.890.991.00.960.3
0.190.42-0.79-0.85-0.79-0.69-0.750.950.96-0.960.99-0.93-0.91-0.920.990.960.950.26
-0.14-0.460.760.930.870.770.75-0.94-0.95-0.96-0.970.980.980.95-0.97-0.95-0.93-0.33
0.160.48-0.71-0.89-0.82-0.74-0.780.950.960.99-0.97-0.93-0.94-0.90.990.960.950.2
-0.09-0.540.770.890.80.690.8-0.93-0.94-0.930.98-0.930.950.98-0.96-0.94-0.94-0.49
-0.04-0.490.680.980.930.860.74-0.92-0.93-0.910.98-0.940.950.88-0.94-0.93-0.87-0.28
-0.25-0.50.760.790.690.560.77-0.89-0.89-0.920.95-0.90.980.88-0.93-0.89-0.95-0.53
0.070.56-0.73-0.89-0.81-0.71-0.840.980.990.99-0.970.99-0.96-0.94-0.930.990.970.31
-0.080.62-0.7-0.89-0.81-0.72-0.881.01.00.96-0.950.96-0.94-0.93-0.890.990.960.29
0.10.65-0.66-0.8-0.69-0.57-0.890.970.960.95-0.930.95-0.94-0.87-0.950.970.960.4
0.050.42-0.31-0.2-0.2-0.11-0.410.310.30.26-0.330.2-0.49-0.28-0.530.310.290.4
Click cells to compare fundamentals

Tinavi Medical Account Relationship Matchups

Tinavi Medical income statement Accounts

201920202021202220232024 (projected)
Tax Provision(8.7M)(14.2M)(22.0M)(31.8M)10.6M11.1M
Net Interest Income387.9K1.6M2.4M(2.6M)(3.7M)(3.5M)
Interest Income459.5K1.6M5.8M1.4M2.8M2.1M
Interest Expense387.9K1.6M3.3M3.9M6.4M6.7M
Selling General Administrative128.2M89.3M83.9M112.6M174.0M105.6M
Total Revenue229.6M135.9M156.0M156.2M210.0M170.9M
Gross Profit195.0M104.6M106.1M102.6M149.4M126.3M
Other Operating Expenses1.4M7.0M1.3M302.6M348.0M365.4M
Operating Income(44.8M)(71.2M)(103.5M)(146.4M)(197.8M)(187.9M)
Net Income From Continuing Ops(34.2M)(54.2M)(82.7M)(112.3M)(161.3M)(153.2M)
Ebit(66.7M)(100.6M)(140.9M)(148.5M)(133.7M)(140.4M)
Research Development77.0M74.1M109.8M122.6M140.3M92.3M
Ebitda(37.0M)(62.6M)(66.0M)(95.7M)(86.1M)(81.8M)
Cost Of Revenue34.6M31.3M50.0M53.6M60.6M44.7M
Total Operating Expenses274.4M207.1M259.5M302.6M407.8M256.7M
Reconciled Depreciation7.7M8.3M35.3M44.5M40.6M22.3M
Income Before Tax(42.8M)(68.4M)(104.7M)(144.2M)(150.7M)(143.2M)
Net Income Applicable To Common Shares(31.0M)(54.5M)(79.9M)(114.4M)(103.0M)(97.8M)
Net Income(31.0M)(54.5M)(79.9M)(110.6M)(156.4M)(148.6M)
Income Tax Expense(8.7M)(14.2M)(22.0M)(34.4M)(31.0M)(29.5M)
Minority Interest11.0M30.5M2.7M1.8M4.9M8.2M

Currently Active Assets on Macroaxis

Other Information on Investing in Tinavi Stock

Tinavi Medical Techn Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tinavi Medical shareholders. The income statement also shows Tinavi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).